[Federal Register Volume 62, Number 82 (Tuesday, April 29, 1997)]
[Notices]
[Pages 23250-23251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-10981]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Statement of Organization, Functions, and Delegations of
Authority
Part D (Food and Drug Administration), Chapter DA, Office of the
Commissioner, of the Statement of Organization, Functions, and
Delegations of Authority for the Department of Health and Human
Services (DHHS) (35 FR 3685, February 25, 1970, and 60 FR 56605,
November, 9, 1995, as amended most recently in pertinent part at 54 FR
50536, December 7, 1989) is amended to reflect revised functions and
title change for the former Executive Secretariat to the newly
established Office of Executive Secretariat (OES), Office of the
Commissioner, Food and Drug Administration (FDA).
The newly established OES will continue to serve as the focal point
for the coordination, identification, development, and implementation
of the agency's highest program priorities for the Commissioner. The
OES staff will advise the Commissioner, Deputy Commissioners, Senior
Staff members and other key agency officials on all activities that
affect agencywide programs, projects and initiatives. This
reorganization will simplify the organizational structure within the
Office of the Commissioner. This action will further enhance and
streamline the management and coordination of the agency's Executive
Secretariat functions.
The proposed revisions are as follows:
1. Delete the Office of Executive Operations (DAB) under the Office
of the Commissioner (DA), in its entirety and replace with the
following:
Office of Executive Secretariat (DAB). Coordinates identification
of and expedites development and implementation of the agency's highest
program priorities and initiatives for the Commissioner.
Develops and maintains management information necessary for
monitoring the Commissioner's and agency's goals and priorities.
Advises the Commissioner, Deputy Commissioners, Senior Staff
members and other key agency officials on all activities that affect
agencywide programs, projects, and initiatives. Informs appropriate
agency staff of the decisions and assignments made by the Commissioner
and Deputy Commissioners.
Assures that materials in support of recommendations presented for
the
[[Page 23251]]
Commissioner's consideration are comprehensive, accurate, fully
discussed and encompass the issues involved.
Provides correspondence control for the Commissioner and controls
and processes all agency public correspondence directed to the
Commissioner. Develops and operates tracking systems designed to
identify and resolve early warnings and bottleneck problems with
executive correspondence.
Provides direct support to the Commissioner and Deputy
Commissioners including briefing materials, background information for
meetings, responses to outside inquiries, and maintenance and control
of the Commissioner's working files.
Performs agencywide assignments involving complex problems and
issues related to agency programs, strategies and activities, including
preparation of special reports for the Department.
Coordinates the agency's communications with the Public Health
Service, DHHS, and the White House including correspondence for the
Assistant Secretary for Health and Secretarial signatures.
2. Delete the subparagraph Executive Secretariat (DAB-1), under the
Office of Executive Operations (DAB) in its entirety.
3. Delete the subparagraph Program Management Staff (DAB-2), under
the Office of Executive Operations (DAB) in its entirety.
4. Prior Delegations of Authority. Pending further delegations,
directives, or orders by the Commissioner of Food and Drugs, all
delegations of authority to positions of the affected organizations in
effect prior to this date shall continue in effect in them or their
successors.
Dated: March 14, 1997.
Michael A. Friedman,
Lead Deputy Commissioner for the Food and Drug Administration.
[FR Doc. 97-10981 Filed 4-28-97; 8:45 am]
BILLING CODE 4160-01-F
